Xiaflex and Nail care for newborns - a phase IV clinical study of FDA data
We study 4,357 people who take Xiaflex or have Nail care for newborns. No report of Nail care for newborns is found in people who take Xiaflex.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Xiaflex?
Xiaflex has active ingredients of collagenase clostridium histolyticum. eHealthMe is studying from 4,357 Xiaflex users for its effectiveness, alternative drugs and more.
What is Nail Care For Newborns?
Nail care for newborns: no further information found.
Do you take Xiaflex and have Nail care for newborns?Check whether Nail care for newborns is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Nail care for newborns and when was it recovered:
Expand to all the drugs that have ingredients of collagenase clostridium histolyticum:
Alternative drugs to, pros and cons of Xiaflex:
- Xiaflex (4,357 reports)
Nail care for newborns treatments and more:
COVID vaccines that are related to Nail care for newborns:
- Nail care for newborns in Moderna COVID Vaccine
- Nail care for newborns in Pfizer BioNTech Covid Vaccine
- Nail care for newborns in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Nail care for newborns:
All the conditions that are associated with Nail care for newborns:
How the study uses the data?
The study uses data from the FDA. It is based on collagenase clostridium histolyticum (the active ingredients of Xiaflex) and Xiaflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Itching and Hepatic Encephalopathy - a second ago
- Cytomel and Cholecystitis Chronic - a second ago
- Tylenol W/ Codeine vs. Prozac - 4 seconds ago
- Norvir and Jaundice Acholuric - 12 seconds ago
- Moxifloxacin and Intervertebral Discitis - 16 seconds ago
- Promethazine and Ageusia - 16 seconds ago
- Zymaxid and Eye Inflammation - 16 seconds ago
- Tobi and Insomnia - 18 seconds ago
- Evista and Phenytoin drug interaction - 18 seconds ago
- Humulin L and Jardiance drug interaction - 20 seconds ago